Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$88K Sell
189
-30
-14% -$12.6K 0.05% 431
2026
Q1
$83K Sell
219
-156
-42% -$66.8K 0.06% 381
2025
Q4
$160K Buy
375
+116
+45% +$50.5K 0.08% 305
2025
Q3
$116K Buy
259
+36
+16% +$16.3K 0.06% 493
2025
Q2
$109K Sell
223
-54
-19% -$30.8K 0.06% 502
2025
Q1
$171K Buy
277
+30
+12% +$17.1K 0.11% 203
2024
Q4
$131K Hold
247
0.08% 356
2024
Q3
$149K Buy
247
+11
+5% +$6.24K 0.09% 308
2024
Q2
$128K Buy
236
+17
+8% +$9.74K 0.08% 358
2024
Q1
$141K Buy
219
+21
+11% +$12.8K 0.09% 309
2023
Q4
$116K Buy
198
+54
+38% +$30.2K 0.08% 398
2023
Q3
$75K Buy
144
+31
+27% +$16.1K 0.06% 580
2023
Q2
$61K Buy
113
+87
+335% +$47.6K 0.05% 692
2023
Q1
$14K Hold
26
0.01% 1139
2022
Q4
$13K Hold
26
0.01% 1185
2022
Q3
$12K Sell
26
-203
-89% -$97.6K 0.01% 1177
2022
Q2
$108K Sell
229
-30
-12% -$14.6K 0.09% 371
2022
Q1
$131K Buy
259
+123
+90% +$59K 0.09% 342
2021
Q4
$72K Buy
+136
New +$65.3K 0.1% 320

Other funds holding CHE

Covestor's CHE Position: Q2 2026 in Review

Covestor reduced its Chemed (CHE) stake by 14% in Q2 2026, selling an estimated $12.6K and leaving 189 shares worth $88K. The position accounts for 0.05% of the portfolio, ranked #431.

Covestor first reported a position in CHE in Q4 2021 and has held it in 19 quarters since. The position peaked at $171K in Q1 2025. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Covestor held 189 shares of Chemed worth $88K as of Q2 2026.
  • Covestor sold 30 Chemed shares in Q2 2026, an estimated $12.6K.
  • Chemed made up 0.05% of Covestor's portfolio in Q2 2026, its #431 holding.
  • Covestor first reported a position in Chemed in Q4 2021 and has held it in 19 quarters since.
  • Covestor's Chemed position peaked at $171K in Q1 2025.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.